Researchers from The University of Nottingham have found that balanced activity in the brain’s prefrontal cortex is necessary for attention.
The research helps to make sense of attention deficits in people suffering from cognitive disorders — like schizophrenia — who often find it hard to sustain their attention. This has a significant effect on many aspects of their lives, including the ability to follow conversations, drive a car and hold down a job.
Activity in a healthy brain is controlled by inhibitory signals between neurons. The research shows that disrupting this healthy inhibition may be just as bad for attention as reducing neuron firing. It is often assumed that increasing brain activity has cognitive benefits, but the findings show that this is not always the case.
The research was carried out by a team in the University’s School of Psychology and involved inhibiting or disinhibiting the prefrontal cortex in rats and monitoring the effect. The researchers found that both of these extremes resulted in attentional deficits and that the ability to pay attention required an appropriate balance where neuron-firing was kept within a certain range.
Schizophrenia and attention deficits
Studies of the brain in people with schizophrenia suggest aberrant neuron-firing in the prefrontal cortex. There is evidence that neuron firing in this part of the brain is often too high or too low. Credit University of Nottingham.
Studies of the brain in people with schizophrenia suggest aberrant neuron-firing in the prefrontal cortex. There is evidence that neuron firing in this part of the brain is often too high or too low.
Dr Tobias Bast, who led the study together with first author Dr Marie Pezze, said: “The implication of our findings is that the abnormalities we see in the prefrontal cortex of schizophrenia patients, for example, are indeed a plausible cause of the attention deficit these patients have.
“It also means that if we want to treat this pharmacologically, we can’t just boost activity of the prefrontal cortex or inactivate it, because that would actually result in an impairment. What we need to do is look at restoring balance of activity through drugs which keep the activity within a certain range.”
Cognitive deficits associated with schizophrenia
In people with schizophrenia, cognitive deficits — such as problems with attention — are less striking than other issues associated with the disorder, such as hallucinations, but are nevertheless a major problem.
Dr Bast said: “Initially people focused on the so-called ‘psychotic symptoms’, including hallucinations and delusions, so that’s what probably comes to mind when you think of schizophrenia. They have been in the fore because they have been so striking and that’s why referrals are made. But these can be treated, at least in a large proportion of patients, by using anti-psychotic medication, which we have had since the late 1950s.
“The problem is that unfortunately anti-psychotic drugs don’t improve cognitive deficits which are very debilitating, affecting many aspects of the patients’ lives. Cognitive deficits are a big problem and something that is currently not treated so finding something that helps this is really important.”
The researchers plan to study new treatments to improve attentional problems caused by imbalanced brain activity. In addition to schizophrenia, such treatments may also help in other cognitive disorders where disrupted control of brain activity has been implicated, including in the early stages of Alzheimer’s disease.
Notes about this neuroscience research
The paper was written by Dr Bast with Dr Pezze and PhD student Stephanie McGarrity from the University’s School of Psychology, alongside Dr Rob Mason, and Professor Kevin Fone from the School of Life Sciences. The research was funded by the Leverhulme Trust, the Royal Society and The University of Nottingham.
Contact: Fraser Wilson – University of Nottingham
Source: University of Nottingham press release
Image Source: The image is adapted from the University of Nottingham press release.
Original Research: Full open access research for “Too Little and Too Much: Hypoactivation and Disinhibition of Medial Prefrontal Cortex Cause Attentional Deficits” by Marie Pezze, Stephanie McGarrity, Rob Mason, Kevin C. Fone, and Tobias Bast in Journal of Neuroscience. Published online June 4 2014 doi:10.1523/JNEUROSCI.3450-13.2014
Open Access Neuroscience Abstract
Too Little and Too Much: Hypoactivation and Disinhibition of Medial Prefrontal Cortex Cause Attentional Deficits
Attentional deficits are core symptoms of schizophrenia, contributing strongly to disability. Prefrontal dysfunction has emerged as a candidate mechanism, with clinical evidence for prefrontal hypoactivation and disinhibition (reduced GABAergic inhibition), possibly reflecting different patient subpopulations. Here, we tested in rats whether imbalanced prefrontal neural activity impairs attention. To induce prefrontal hypoactivation or disinhibition, we microinfused the GABA-A receptor agonist muscimol (C4H6N2O2; 62.5, 125, 250 ng/side) or antagonist picrotoxin (C30H34O13; 75, 150, 300 ng/side), respectively, into the medial prefrontal cortex. Using the five-choice serial reaction time (5CSRT) test, we showed that both muscimol and picrotoxin impaired attention (reduced accuracy, increased omissions). Muscimol also impaired response control (increased premature responses). In addition, muscimol dose dependently reduced open-field locomotor activity, whereas 300 ng of picrotoxin caused locomotor hyperactivity; sensorimotor gating (startle prepulse inhibition) was unaffected. Therefore, infusion effects on the 5CSRT test can be dissociated from sensorimotor effects. Combining microinfusions with in vivo electrophysiology, we showed that muscimol inhibited prefrontal firing, whereas picrotoxin increased firing, mainly within bursts. Muscimol reduced and picrotoxin enhanced bursting and both drugs changed the temporal pattern of bursting. Picrotoxin also markedly enhanced prefrontal LFP power. Therefore, prefrontal hypoactivation and disinhibition both cause attentional deficits. Considering the electrophysiological findings, this suggests that attention requires appropriately tuned prefrontal activity. Apart from attentional deficits, prefrontal disinhibition caused additional neurobehavioral changes that may be relevant to schizophrenia pathophysiology, including enhanced prefrontal bursting and locomotor hyperactivity, which have been linked to psychosis-related dopamine hyperfunction.
“Too Little and Too Much: Hypoactivation and Disinhibition of Medial Prefrontal Cortex Cause Attentional Deficits” by Marie Pezze, Stephanie McGarrity, Rob Mason, Kevin C. Fone, and Tobias Bast in Journal of Neuroscience, June 4 2014 doi:10.1523/JNEUROSCI.3450-13.2014